Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V37092 | (D-Pro2)-β-Casomorphin (1-5) (bovine) | (D-Pro2)-β-Casomorphin (1-5) (bovine) is a peptide compound. | |
|
V37042 | (D-Pro2,D-Phe7,D-Trp9)-Substance P | 77275-70-8 | [D-Pro2,D-Phe7,D-Trp9] Substance P is an analog of Substance P. |
|
V37043 | (D-Pro2,D-Trp7·9)-Substance P | 80434-86-2 | [D-Pro2,D-Trp7,9] Substance P, an analog of Substance P, is a weak agonist and an effective, specific and competitive Substance P antagonist. |
|
V37045 | (D-Pro4,D-Trp7·9,Nle11)-Substance P (4-11) | 89430-34-2 | [D-Pro4,D-Trp7,9,Nle11] Substance P (4-11) is a potent neurokinin NK1 antagonist. |
|
V37044 | (D-Pro4,D-Trp7·9·10)-Substance P (4-11) | 86917-57-9 | [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist. |
|
|
V37046 | (D-Pro4,D-Trp7·9·10,Val8)-Substance P (4-11) | (D-Pro4,D-Trp7·9·10,Val8)-Substance P (4-11) is a peptide compound. | |
|
|
V37005 | (D-Ser13)-Somatostatin-14 | (D-Ser13)-Somatostatin-14 is a peptide compound. | |
|
V36773 | (D-Thr6,D-Trp8·9,L-alaninol15)-Galanin (1-15) | 150940-97-9 | (D-Thr6,D-Trp8·9,L-alaninol15)-Galanin (1-15) is a peptide compound. |
|
V36886 | (D-Trp11)-Neurotensin | 73634-68-1 | [D-Trp11]-Neurotensin is an analog of Neurotensin (NT) and is a selective antagonist of NT in perfused rat hearts but works as a full agonist in guinea pig atria and rat gastric strips. |
|
V36965 | (D-Trp12,Tyr34)-pTH (7-34) amide (bovine) | 118102-98-0 | (D-Trp12,Tyr34)-pTH (7-34) amide (bovine) is a potent competitive parathyroid hormone (PTH) antagonist (inhibitor) with Ki of 69 nM in bovine kidney cortical membranes. |
|
|
V36774 | (D-Trp2)-Galanin (1-29) (human) | (D-Trp2)-Galanin (1-29) (human) is a peptide compound. | |
|
|
V36860 | (D-Trp32)-Neuropeptide Y (human, rat) | 178861-83-1 | (D-Trp32)-Neuropeptide Y (human, rat) is a peptide compound. |
|
V36866 | (D-Trp32)-Neuropeptide Y (porcine) | 153549-78-1 | (D-Trp32)-Neuropeptide Y (porcine) is a peptide compound. |
|
V36837 | (D-Trp7,Ala8,D-Phe10)-α-MSH (6-11) amide | 87616-84-0 | (D-Trp7,Ala8,D-Phe10)-α-MSH (6-11) amide is a peptide compound. |
|
V37006 | (D-Trp8)-Somatostatin-14 | 58976-46-8 | [D-Trp8] Somatostatin-14 is a tetradecapeptide that is a more potent somatostatin analog than native somatostatin. |
|
V37007 | (D-Trp8,D-Cys14)-Somatostatin-14 | 61950-59-2 | (D-Trp8,D-Cys14)-Somatostatin-14 is a synthetic analog of somatostatin. |
|
V36887 | (D-Tyr11)-Neurotensin | 64088-62-6 | (D-Tyr11)-Neurotensin is a peptide compound. |
|
V36879 | (D-Tyr27·36,D-Thr32)-Neuropeptide Y (27-36) | 163887-48-7 | (D-Tyr27·36,D-Thr32)-Neuropeptide Y (27-36) is a peptide compound. |
|
V36735 | (D-Val22)-Big Endothelin-1 fragment (16-38) (human) | 158884-64-1 | (D-Val22)-Big Endothelin-1 fragment (16-38) (human) is a peptide compound. |
|
|
V36891 | (Dab9)-Neurotensin (8-13) | (Dab9)-Neurotensin (8-13) is a peptide compound. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
